Critical Care News and Research

RSS

CorMedix submits IND application to FDA for Neutrolin

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.

25 Sep 2014

RDT receives FDA clearance for Tempus Pro advanced medical monitor

RDT is pleased to announce that, following CE and other market approvals, it has received 510k clearance by the US Food and Drug Administration for the addition to the Tempus Pro medical monitor of: 12 Lead ECG recording interpretation, real-time arrhythmia detection, ST and QT monitoring and alarming (unique to a fully-featured pre-hospital transport monitor) an additional two channels of invasive blood pressure (four in total), Masimo rainbow SET co-oximetry, video laryngoscope and ultrasound.

24 Sep 2014

MediValve successfully completes post-market clinical evaluation of acWire Guidewire

MediValve, Ltd., a Trendlines portfolio company, today announced that it has successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire.

24 Sep 2014

New evidence-based guidelines for prevention, treatment of POAF

The American Association for Thoracic Surgery has released new evidence-based guidelines for the prevention and treatment of perioperative and postoperative atrial fibrillation (POAF) and flutter for thoracic surgical procedures.

23 Sep 2014

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

23 Sep 2014

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Avalon Ventures today announced the launch of two new companies formed through its collaboration with GlaxoSmithKline to fund and launch up to 10 early-stage life science companies.

23 Sep 2014

Study suggests potential treatment for cardiovascular disease in people with apoE4 gene variant

Researchers at UT-Southwestern Medical Center have found that the most common variant of the circulating protein apolipoprotein E, called apoE3, helps repair the lining of blood vessels. Individuals with another variant, called apoE4, do not get the benefit of this repair, putting them at higher risk for cardiovascular disease.

18 Sep 2014

Sphere Medical introduces new Proxima miniaturised blood gas analyser at AAGBI 2014

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.

17 Sep 2014

Medicone Medical Response selected as one of fastest growing companies in the US

MedicOne Medical Response, a leading provider emergency and non-emergency ambulance transport services, has been selected by Inc. Magazine as one of the fastest growing private companies in America.

15 Sep 2014

Instrumentation Laboratory announces launch of HemosIL Direct Thrombin Inhibitor Assay in Europe

Instrumentation Laboratory today announced the commercialization in Europe of their HemosIL Direct Thrombin Inhibitor (DTI) Assay. When used in conjunction with HemosIL Dabigatran Calibrators and Controls, this test offers an automated solution for the measurement of dabigatran, a direct oral anticoagulant (DOAC).

15 Sep 2014

Study: High-dose prescribing increases by 23% in Canada

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new research.

15 Sep 2014

Peer pressure influences adherence to hand hygiene

Nationally, hand hygiene adherence by healthcare workers remains staggeringly low despite its critical importance in infection control.

11 Sep 2014

Improper removal of personal protective gear increases risk for Ebola health care workers

A team of American infectious disease and critical care experts is alerting colleagues caring for Ebola patients that how they remove their personal protective gear can be just as crucial as wearing it to prevent exposure to the deadly virus.

10 Sep 2014

Study shows xenon gas treatment reduces brain damage after head injury

Treatment with xenon gas after a head injury reduces the extent of brain damage, according to a study in mice.

10 Sep 2014

Most prevalent form of discrimination is due to mental illness and homelessness

Vulnerable populations in ethnically diverse Toronto reported more discrimination by health care workers based on their housing status, mental health or substance abuse issues than race, a new study has found.

9 Sep 2014

Treatment with xenon gas after head injury reduces extent of brain damage

Treatment with xenon gas after a head injury reduces the extent of brain damage, according to a study in mice.

9 Sep 2014

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago.

9 Sep 2014

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.

4 Sep 2014

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Wet AMD is characterized by abnormal growth of blood vessels in the macula (the area of the eye containing vision-enabling photoreceptors), and is responsible for the vast majority of severe vision loss in the industrialized world.

4 Sep 2014

New paper highlights ways to improve outcomes of Ebola virus infection

The largest-ever Ebola virus disease outbreak is ravaging West Africa, but with more personnel, basic monitoring, and supportive treatment, many of the sickest patients with Ebola virus disease do not need to die, note the authors of a new paper published ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

30 Aug 2014

Critical Care News and Research

CorMedix submits IND application to FDA for Neutrolin

RDT receives FDA clearance for Tempus Pro advanced medical monitor

MediValve successfully completes post-market clinical evaluation of acWire Guidewire

New evidence-based guidelines for prevention, treatment of POAF

Yale University researchers study potential new treatment to reverse effects of pulmonary fibrosis

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Study suggests potential treatment for cardiovascular disease in people with apoE4 gene variant

Sphere Medical introduces new Proxima miniaturised blood gas analyser at AAGBI 2014

Medicone Medical Response selected as one of fastest growing companies in the US

Instrumentation Laboratory announces launch of HemosIL Direct Thrombin Inhibitor Assay in Europe

Study: High-dose prescribing increases by 23% in Canada

Peer pressure influences adherence to hand hygiene

Improper removal of personal protective gear increases risk for Ebola health care workers

Study shows xenon gas treatment reduces brain damage after head injury

Most prevalent form of discrimination is due to mental illness and homelessness

Treatment with xenon gas after head injury reduces extent of brain damage

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

New paper highlights ways to improve outcomes of Ebola virus infection

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News